Hill Happenings
Tracking the Hill's briefings, receptions, workshops, and more.



Tracking the Hill's briefings, luncheons, receptions, and more.
Filter by tags: House SideSenate Side | After 5Food

Back to All Events

The Cost of Cures: Drug Price Controls vs. Biopharmaceutical Innovation

  • 385 Russell Senate Office Building (map)

There is an increasingly intense focus in Washington on reducing the price of drugs to bring down health care costs. President Trump has proposed a plan that would use an international pricing index model for drugs covered under Medicare Part B. There are proposals from both sides of the aisle in Congress as well, including various forms of government-led arbitration and changes to U.S. patent laws. But much of this debate is taking place without systematic consideration of what effect, if any, mandated drug-price reductions would have on biopharmaceutical innovation and U.S. industry competitiveness.

Please join ITIF and the American Action Forum for an expert panel discussion and debate delving into this critical issue.